Skip to main content

Table 1 Intra-group and inter-group differences in the first follow up (from the beginning of the treatment to 9 months) and in the second follow-up (from the beginning of the treatment to 18 months)

From: Clinical and radiographic evaluation of biodentine versus calcium hydroxide in primary teeth pulpotomies: a retrospective study

  Calcium hydroxide
9 months
Biodentine
9 months
Calcium hydroxide
18 months
Biodentine
18 months
Intra-group
p- value
CH
(OR: CI 95%)
Intra-group
p- value
Biodentine
OR CI 95%
Inter-group
p- value
9 months
OR CI 95%
Inter-group
p- value
18 months
OR CI 95%
Sex 91 males, 80 females, 98 males, 90 females, 88 males, 75 females, 94 males, 85 females,  
Age (years) 7.7 ± 1.6 7.5 ± 1.5 7.5 ± 1.5 7.6 ± 1.7  
Total success 171 (85.5%) 188 (94%) 163 (81.5%) 179 (89.5%) 0.28 (1.34: 0.79–2.28) 0.1 (1.84: 0.88–3.85) 0.005* (0.38: 0.19–0.76) 0.02* (0.52: 0.29–0.92)
Clinical success 182 (91%) 195 (97.5%) 179 (89.5%) 193 (96.5%) 0.61 (1.19: 0.61–2.3) 0.56 (1.41:0.44–4.53) 0.005* (0.26: 0.09–0.71) 0.006* (0.31: 0.13–0.74)
Radiographic success 171 (85.5%) 188 (94%) 166 (83%) 181 (90.5%) 0.49 (1.21:0.7–2.07) 0.19 (1.64:0.78–3.48) 0.005* (0.38: 0.19–0.76) 0.027* (0.51: 0.28–0.93)
Pain 11 (5.5%) 2 (1%) 13 (6.5%) 3 (1.5%) 0.67 (0.84:0.37–1.92) 0.65 (0.66:0.11–4.01) 0.011* (5.76:1.26–26.34) 0.01* (4.57: 1.28–16.28)
Percussion 9 (4.5%) 1 (0.5%) 9 (4.5%) 2 (1%) 1 (1:0.39–2.57) 0.56 (0.5:0.04–5.53) 0.01* (9.38:1.18–74.72) 0.03* (4.66: 1–21.87)
Swelling 12 (6%) 1 (0.5%) 12 (6%) 1 (0.5%) 1 (1: 0.44–2.28) 1 (1:0.06–16.1) 0.002* (12.7:1.64–98.64) 0.002* (12.7: 1.64–98.64)
Mobility 2 (1%) 1 (0.5%) 3 (1.5%) 1 (0.5%) 0.65 (0.11–4.01) 1 (1:0.06–16.1) 0.56 (2.01:0.18–22.35) 0.32 (3.03:0.31–29.38)
Esfoliation 16 (8%) 6 (3%) 18 (9%) 9 (4.5%) 0.72 (0.88:0.43–1.78) 0.43 (0.66:0.23–1.88) 0.028* (2.81:1.08–7.34) 0.07 (2.1:0.92–4.79)
Widening 13 (6.5%) 5 (2.5%) 16 (8%) 8 (4%) 0.56 (0.8:0.37–1.71) 0.4 (0.62:0.2–1.91) 0.054* (2.71: 0.95–7.75) 0.09 (2.09:0.87–4.99)
Resorption 14 (7%) 5 (2.5%) 17 (8.5%) 8 (4%) 0.57 (0.81:0.39–1.69) 0.4 (0.62:0.2–1.91) 0.034* (2.94:1.04–8.31) 0.06 (2.23:0.94–5.29)
Radiolucency 2 (1%) 2 (1%) 0 (0%) 3 (1.5%) 0.16 (0) 0.65 (0.66:0.11–4.01) 1 (1:0.14–7.17) 0.08 (0)
  1. Chi-square test *p < 0.05